Drug addiction is caused by a combination of changes in brain chemistry, genetic vulnerability, environmental stress, and psychological factors. No single cause explains why one person becomes addicted while another does not. Roughly 50% of a person’s risk comes from their genes, with the rest shaped by life experiences, mental health, age of first use, and the type of substance involved.
How Drugs Rewire the Brain’s Reward System
The core mechanism of addiction starts in a circuit deep in the brain that evolved to reinforce survival behaviors like eating and bonding. This reward circuit runs between a region near the brain stem (the ventral tegmental area) and a structure called the nucleus accumbens. Dopamine, a chemical messenger, flows between them to create feelings of pleasure and motivation. Every addictive substance, from alcohol to opioids to nicotine, artificially floods this circuit with dopamine far beyond what any natural reward produces.
The brain responds to this flood by dialing down its own dopamine output. In people who develop addiction, dopamine release in the nucleus accumbens drops significantly, and the number of dopamine receptors shrinks. Brain imaging studies in people addicted to cocaine, heroin, and alcohol consistently show this pattern: fewer receptors and a blunted dopamine response compared to healthy individuals. The result is that everyday pleasures lose their pull. Food, social connection, hobbies that once felt rewarding now barely register, while the drug remains the only reliable source of relief.
This dopamine deficit persists well beyond the initial withdrawal period. Animal studies show that reduced dopamine activity continues long after physical withdrawal symptoms resolve. In morphine-dependent rats, the suppressed dopamine function eventually returns to normal, but the timeline varies and can stretch for weeks or months in proportion to the duration of use. This lingering chemical imbalance helps explain why cravings and vulnerability to relapse persist long after someone stops using.
Loss of Impulse Control
Addiction also damages the brain’s braking system. The prefrontal cortex, the region behind your forehead responsible for decision-making, impulse control, and weighing consequences, becomes progressively impaired with chronic drug use. Imaging studies show that people with addiction have reduced activity in the prefrontal cortex, particularly in areas involved in self-control, behavioral monitoring, and flexible thinking. This means the part of the brain you need most to resist a craving is the part most weakened by the drug itself.
The loss of prefrontal function shows up in specific, measurable ways. People with addiction demonstrate greater impulsivity, difficulty shifting attention away from drug-related cues, and reduced ability to detect and correct their own errors. This prefrontal dysfunction contributes to the compulsive drug-taking, intense cravings, and the puzzling inability of many addicted individuals to recognize the severity of their own condition. It is not a failure of willpower. The neural hardware for self-regulation has been physically altered.
Why Genetics Account for Half the Risk
Twin and family studies consistently show that genetic factors account for about 50% of a person’s vulnerability to addiction. The range varies by substance: alcohol use disorder has a heritability of 50 to 64%, opioid use disorder around 50%, and cannabis and cocaine use disorders between 40 and 80%. Nicotine dependence ranges widely from 30 to 70%.
Large-scale genetic studies have pinpointed specific genes involved. For alcohol addiction, variants in genes that control how the body metabolizes alcohol (ADH1B and ALDH2) play a major role. People who carry certain versions of these genes break down alcohol differently, making the experience more or less unpleasant and thereby influencing how much they drink. For nicotine, genes affecting receptors in the brain that nicotine binds to (the CHRNA5-A3-B4 cluster) are among the strongest risk factors identified. Opioid addiction involves a gene (OPRM1) that codes for the brain’s primary opioid receptor, the very lock that opioid drugs fit into.
Having these genetic variants does not guarantee addiction. They shift the odds. Someone with a strong family history of alcoholism may find that alcohol produces an unusually powerful sense of relief or pleasure, or that their brain is slower to signal “enough.” These inherited differences interact with everything else in a person’s life to determine whether casual use escalates.
Childhood Trauma and Early Environment
Adverse childhood experiences, including abuse, neglect, household dysfunction, and witnessing violence, are among the strongest environmental predictors of addiction. Adults with any history of adverse childhood experiences have a 4.3-fold higher likelihood of developing a substance use disorder compared to adults without such a history. That risk compounds: for each additional type of adverse experience a person reports, the odds of a substance use disorder increase by roughly 50%.
The connection is not purely psychological. Chronic stress during childhood physically reshapes the developing brain’s stress-response systems. Children exposed to repeated trauma tend to have an overactive stress response and an underactive reward system, a combination that makes substances feel like the first effective relief they have ever experienced. Childhood sexual abuse, neglect, and witnessing trauma during childhood are independently correlated with developing co-occurring addiction and psychiatric disorders in adulthood.
Social Isolation and Environment
The environment you live in matters beyond childhood. Social isolation is a powerful driver of addictive behavior, and animal research helps illustrate why. Rats raised in isolation from weaning through adulthood show clear increases in impulsive and compulsive behavior compared to socially housed rats. In reward-choice tests, isolated rats consistently chose the riskier, higher-payoff option, a hallmark of the impulsivity seen in addiction. They also showed compulsive overeating patterns and heightened anxiety-like behavior when rewarding food was removed.
At a brain level, socially isolated animals produced larger dopamine surges in the nucleus accumbens in response to reward-associated cues. Their reward circuits had essentially been sensitized, primed to overreact to pleasurable stimuli. This mirrors what researchers observe in humans: people with fewer social connections, less community support, and greater loneliness are at elevated risk. The implication is that addiction is not simply a property of the drug or the individual. It emerges from the interaction between a person and the world they inhabit.
Mental Health and Dual Diagnosis
About 36.5% of adults with a substance use disorder also meet criteria for a psychiatric condition like depression, anxiety, PTSD, or bipolar disorder. The relationship runs in both directions. Untreated depression or anxiety can drive someone to self-medicate with alcohol or drugs, while chronic substance use can trigger or worsen psychiatric symptoms. Among those with dual diagnosis, the correlates are stark: higher rates of violent behavior, homelessness, incarceration, suicide attempts, and poorer quality of life.
This overlap is not coincidental. Many of the same brain circuits and chemical messengers involved in mood regulation are the ones disrupted by addictive substances. A person whose brain already produces less dopamine or serotonin due to depression may find that a drug temporarily corrects that deficit, creating an especially powerful reinforcement loop. Effective treatment for addiction in these cases requires addressing both conditions simultaneously, since treating one while ignoring the other dramatically increases the chance of relapse.
Why Adolescents Are Especially Vulnerable
The age at which someone first uses a substance is one of the most reliable predictors of whether they will develop an addiction. The adolescent brain is still under construction, and the construction schedule is uneven. The emotional and reward-processing regions deeper in the brain mature earlier, while the prefrontal cortex, responsible for judgment and impulse control, is not fully developed until the mid-20s. The analogy researchers use: a teenager has a fully functional accelerator but the brakes have not been installed yet.
This mismatch means adolescents experience the rewarding effects of drugs intensely while lacking the neural infrastructure to regulate their response. Drug exposure during this critical period can interfere with the normal pruning process, in which the brain streamlines its connections starting around age 11 or 12. Animal studies show that adolescent rats exposed to alcohol sustain significantly more damage to prefrontal and memory-related brain regions than adult rats given the same exposure. Long-term alcohol exposure during the equivalent of adolescence caused dramatic damage to brain areas involved in learning and language.
Early drug use may alter the trajectory of brain maturation itself, contributing to lasting cognitive impairment and a substantially higher susceptibility to addiction that persists into adulthood.
How Tolerance Locks the Cycle in Place
Once regular use is established, the body’s own adaptation mechanisms accelerate the slide toward addiction. With repeated exposure to a drug, particularly opioids, cells reduce the number of receptors available for the drug to bind to. Some receptors are pulled inside the cell and broken down. Others become less responsive to signaling. The practical effect is that the same dose produces a weaker response, driving the person to use more to achieve the original effect.
Tolerance is not just about needing more of the drug. It reflects a fundamental shift in how the body maintains balance. The brain and body mount compensatory responses that oppose the drug’s effects, and these opponent processes grow stronger with repeated exposure. When the drug is absent, those compensatory responses are left unopposed, producing withdrawal symptoms that are often the mirror image of the drug’s effects: pain instead of relief, agitation instead of calm, insomnia instead of sedation. This creates a cycle where the person uses not to feel good, but to stop feeling terrible.
How Addiction Is Defined Clinically
Addiction is formally diagnosed as a substance use disorder using 11 criteria that capture the behavioral, physical, and psychological dimensions of the condition. These include cravings, using more than intended, failed attempts to cut back, spending excessive time obtaining or recovering from the substance, neglecting responsibilities, continuing use despite relationship or health problems, giving up activities, using in dangerous situations, tolerance, and withdrawal. Meeting two or three criteria indicates a mild disorder, four or five is moderate, and six or more is severe.
This framework replaced an older system that divided problems into “abuse” and “dependence” as separate conditions. The current approach, based on data from over 200,000 study participants, recognizes addiction as a single spectrum ranging from mild to severe. Craving, added as a criterion in the most recent revision, reflects the central role that intense, intrusive urges play in maintaining the cycle of use.